SCHEMBL26863192

SCHEMBL26863192

Cc1ccc(S(=O)(=O)n2nc(I)c3ccc(O)cc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
SLC9A1 P19634 1/20 0.40
ESR1 P03372 1/20 0.40
KMT2A Q03164 8/20 0.39
MEN1 O00255 5/20 0.39
GAA P10253 1/20 0.39
HTT P42858 2/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
PKM P14618 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYTH2 Q99418 1/20 0.38
POLB P06746 2/20 0.37
ALDH3A1 P30838 1/20 0.37
NOD1 Q9Y239 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MMP2 P08253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26863195 0.89 MAPT (0.49) MAPTSLC9A1KMT2AMEN1GAA
SCHEMBL1593401 0.76 MAPT (0.51) MAPTSLC9A1KMT2AMEN1GAA
SCHEMBL31617556 0.74 MAPT (0.42) MAPTSLC9A1KMT2AMEN1GAA
SCHEMBL2144861 0.70 MAPT (0.50) MAPTSLC9A1KMT2AMEN1GAA
SCHEMBL1099865 0.70 MAPT (0.57) MAPTSLC9A1KMT2AMEN1GAA
SCHEMBL25079222 0.69 ESR1 (0.58) ESR1GAAHTTALDH1A1
SCHEMBL30302190 0.68 NR1H2 (0.53) MAPTSLC9A1KMT2AMEN1GAA
SCHEMBL16752184 0.68 SLC22A12 (0.54) MAPTKMT2AMEN1GAAALDH1A1
SCHEMBL1099850 0.68 ALDH1A1 (0.49) MAPTSLC9A1KMT2AMEN1ALDH1A1
SCHEMBL25169357 0.67 HTR6 (0.47) MAPTSLC9A1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382893-A1 AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY SHIONOGI & CO., LTD. (JP) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382893-A1 AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY ZC3HAV1, ZC3HAV1L, IFNAR1 MAPT 4777/4885SLC9A1 2759/4885ESR1 2406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.